Calcium-sensing Receptor Genetic Variants and Their Association with CKD-MBD in South Indian Tamils

Overview

Journal J Appl Genet

Publisher Springer

Specialty Genetics

Date 2025 Mar 14

PMID 40085338

Authors

G Priyadarshini

A Dhinesh

Sreejith Parameswaran

Jayaprakash Sahoo

Sandhiya Selvarajan

Medha Rajappa

Affiliations

Soon will be listed here.

Abstract

The progressive degradation of the renal parenchyma and reduction of functional nephrons characterise chronic kidney disease (CKD). Disorders of bone mineral metabolism is one of the leading causes of morbidity and mortality in CKD. Calcium-sensing receptor (CASR) allows cells to detect changes in blood calcium levels and regulate its concentration. Hence, we aim to study the relationship between genetic variants of CASR and CKD and their relation with mineral bone disease (MBD). A total of 180 CKD patients and 180 controls were recruited. Bone mineral density of the lumbar spine, hip, and forearm was measured using a dual X-ray absorptiometry (DEXA) scan. Circulating levels of parathyroid hormone (PTH) were measured by ELISA. Genotyping was done by real-time quantitative PCR. A significant difference in the distribution of the GAG haplotype (rs7652589, rs1501899, rs1801725) was observed between CKD patients and controls. Participants with the GT genotype of rs1801725 had lower BMD in the forearm. The TT genotype of rs1801725 was associated with decreased serum calcium levels. A regression model indicated that the GT genotype of rs1801725 and AG and GG genotypes of rs7652589 were significant predictors of forearm BMD. GAG haplotype of CASR SNPs is linked to CKD risk in South Indian Tamils. GT genotype of rs1801725 and AG and GG genotype of rs7652589 are independent predictors of MBD in patients with CKD.

References

Alem A, Sherrard D, Gillen D, Weiss N, Beresford S, Heckbert S . Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000; 58(1):396-9. DOI: 10.1046/j.1523-1755.2000.00178.x. View

Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15(8):2208-18. DOI: 10.1097/01.ASN.0000133041.27682.A2. View

Brown E, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O . Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993; 366(6455):575-80. DOI: 10.1038/366575a0. View

Bucur R, Panjwani D, Turner L, Rader T, West S, Jamal S . Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis. Osteoporos Int. 2014; 26(2):449-58. DOI: 10.1007/s00198-014-2813-3. View

Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y . Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. Am J Kidney Dis. 2015; 66(2):258-65. DOI: 10.1053/j.ajkd.2015.01.009. View

Gautam K, Cherian K, Kapoor N, Thomas N, Paul T . Utility and validation of bone mineral density measurements at forearm in predicting trabecular microarchitecture and central-site osteoporosis in aging Indian postmenopausal women-a promising surrogate?. Aging Med (Milton). 2022; 5(1):30-37. PMC: 8917263. DOI: 10.1002/agm2.12191. View

Grzegorzewska A, Paciorkowski M, Mostowska A, Frycz B, Warchol W, Stolarek I . Associations of the calcium-sensing receptor gene CASR rs7652589 SNP with nephrolithiasis and secondary hyperparathyroidism in haemodialysis patients. Sci Rep. 2016; 6:35188. PMC: 5064403. DOI: 10.1038/srep35188. View

Grzegorzewska A, Frycz B, Swiderska M, Niepolski L, Mostowska A, Jagodzinski P . Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study. BMC Nephrol. 2019; 20(1):436. PMC: 6882244. DOI: 10.1186/s12882-019-1619-0. View

Hendy G, Yang B, Canaff L, Cole D . Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat. 2000; 16(4):281-96. DOI: 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A. View

10.

Inker L, Eneanya N, Coresh J, Tighiouart H, Wang D, Sang Y . New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021; 385(19):1737-1749. PMC: 8822996. DOI: 10.1056/NEJMoa2102953. View

11.

Jadoul M, Albert J, Akiba T, Akizawa T, Arab L, Bragg-Gresham J . Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006; 70(7):1358-66. DOI: 10.1038/sj.ki.5001754. View

12.

Jung J, Foroud T, Eckert G, Flury-Wetherill L, Edenberg H, Xuei X . Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans. J Clin Endocrinol Metab. 2008; 94(3):1042-8. PMC: 2681276. DOI: 10.1210/jc.2008-1861. View

13.

Laster M, Rowan B, Chen H, Schwantes-An T, Sheng X, Friedman P . Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022; 107(9):e3866-e3876. PMC: 9387704. DOI: 10.1210/clinem/dgac318. View

14.

Li H, Zhang J, Long J, Shi J, Luo Y . Calcium-sensing receptor gene polymorphism (rs7652589) is associated with calcium nephrolithiasis in the population of Yi nationality in Southwestern China. Ann Hum Genet. 2018; 82(5):265-271. DOI: 10.1111/ahg.12249. View

15.

Lorentzon M, Lorentzon R, Lerner U, Nordstrom P . Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur J Endocrinol. 2001; 144(3):257-61. DOI: 10.1530/eje.0.1440257. View

16.

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K . Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006; 69(11):1945-53. DOI: 10.1038/sj.ki.5000414. View

17.

Nickolas T, McMahon D, Shane E . Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006; 17(11):3223-32. DOI: 10.1681/ASN.2005111194. View

18.

Nickolas T, Stein E, Dworakowski E, Nishiyama K, Komandah-Kosseh M, Zhang C . Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res. 2013; 28(8):1811-20. PMC: 3720694. DOI: 10.1002/jbmr.1916. View

19.

Pimentel A, Urena-Torres P, Bover J, Fernandez-Martin J, Cohen-Solal M . Bone Fragility Fractures in CKD Patients. Calcif Tissue Int. 2020; 108(4):539-550. PMC: 8052229. DOI: 10.1007/s00223-020-00779-z. View

20.

Stavroulopoulos A, Porter C, Roe S, Hosking D, Cassidy M . Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology (Carlton). 2008; 13(1):63-7. DOI: 10.1111/j.1440-1797.2007.00860.x. View